- Report
- May 2024
- 137 Pages
Global
From €4880EUR$5,524USD£4,276GBP
€5741EUR$6,499USD£5,030GBP
- Report
- May 2024
- 139 Pages
Global
From €4880EUR$5,524USD£4,276GBP
€5741EUR$6,499USD£5,030GBP
- Report
- May 2024
- 134 Pages
Global
From €4880EUR$5,524USD£4,276GBP
€5741EUR$6,499USD£5,030GBP
- Report
- May 2024
- 140 Pages
Global
From €4880EUR$5,524USD£4,276GBP
€5741EUR$6,499USD£5,030GBP
- Report
- May 2024
- 129 Pages
Global
From €4880EUR$5,524USD£4,276GBP
€5741EUR$6,499USD£5,030GBP
- Report
- May 2024
- 130 Pages
Global
From €4880EUR$5,524USD£4,276GBP
€5741EUR$6,499USD£5,030GBP
- Report
- May 2024
- 128 Pages
Global
From €4880EUR$5,524USD£4,276GBP
€5741EUR$6,499USD£5,030GBP
- Report
- May 2024
- 134 Pages
Global
From €4880EUR$5,524USD£4,276GBP
€5741EUR$6,499USD£5,030GBP
- Report
- May 2024
- 139 Pages
Global
From €4880EUR$5,524USD£4,276GBP
€5741EUR$6,499USD£5,030GBP
- Report
- May 2024
- 129 Pages
Global
From €4880EUR$5,524USD£4,276GBP
€5741EUR$6,499USD£5,030GBP
- Report
- May 2024
- 128 Pages
Global
From €4880EUR$5,524USD£4,276GBP
€5741EUR$6,499USD£5,030GBP
- Report
- May 2024
- 140 Pages
Global
From €4880EUR$5,524USD£4,276GBP
€5741EUR$6,499USD£5,030GBP
- Report
- May 2023
- 132 Pages
India
From €2252EUR$2,549USD£1,973GBP
€2649EUR$2,999USD£2,321GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €2650EUR$3,000USD£2,322GBP
€3313EUR$3,750USD£2,902GBP
- Report
- July 2024
- 100 Pages
Global
From €2650EUR$3,000USD£2,322GBP
€3313EUR$3,750USD£2,902GBP
- Report
- March 2024
- 200 Pages
Global
From €3666EUR$4,150USD£3,212GBP
- Report
- August 2024
- 161 Pages
Global
From €2208EUR$2,500USD£1,935GBP
- Report
- August 2024
- 178 Pages
Global
From €2208EUR$2,500USD£1,935GBP
- Report
- July 2024
- 139 Pages
Global
From €2208EUR$2,500USD£1,935GBP
- Report
- December 2023
- 142 Pages
Brazil
From €2208EUR$2,500USD£1,935GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more